Results 171 to 180 of about 55,015 (188)

Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics. [PDF]

Lancet Infect Dis
Ciavarella C, Drakeley C, Price RN, Mueller I, White M.   +4 more
europepmc   +1 more source

Microhaplotype deep sequencing assays to capturePlasmodium vivaxinfection lineages

Kleinecke M, Rumaseb A, Sutanto E, Trimarsanto H, Hoon KS, Osborne A, Manrique P, Peters T, Hawkes D, Benavente ED, Whitton G, Siegel SV, Pearson RD, Amato R, Rai A, Thuy Nhien NT, Chau NH, Assefa A, Degaga TS, Abate DT, Rahim AG, Pasaribu AP, Sutanto I, Alam MS, Pava Z, Mesa TL, Echeverry D, William T, Anstey NM, Grigg MJ, Day N, White NJ, Kwiatkowski DP, Noviyanti R, Neafsey D, Price RN, Auburn S.   +36 more
europepmc   +1 more source

Contribution of Travelers to <i>Plasmodium Vivax</i> Malaria in South West Delhi, India: Cross-Sectional Survey.

JMIR Public Health Surveill
Savargaonkar D, Srivastava B, Yadav CP, Singh MP, Anvikar A, Sharma A, Singh H, Sinha A.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Plasmodium vivax in India

Trends in Parasitology, 2008
Four Plasmodium species cause malaria in humans: Plasmodium vivax is the most widespread and results in pronounced morbidity. India (population >1 billion) is a major contributor to the burden of vivax malaria. With a resurgence in interest concerning the neglected burden of vivax malaria and the completion of the P.
Hema Joshi, Simon Kang’a, Anju Verma, Surendra K Prajapati, Jane M. Carlton   +4 more
openaire   +2 more sources

Cultivation of Plasmodium vivax

Trends in Parasitology, 2008
Establishment of a continuous line of Plasmodium vivax parasite is crucial to understand the parasite's biology; however, this has not yet been achieved. Beginning in the 19th century, there were several efforts to cultivate this malaria parasite but without much success until the late 1980s.
Jetsumon Sattabongkot, Rachanee Udomsangpetch, Osamu Kaneko, Kesinee Chotivanich   +3 more
openaire   +3 more sources

Focus on Plasmodium vivax

Trends in Parasitology, 2002
In Bangkok, Thailand, 3-8 February 2002, the Multilateral Initiative on Malaria convened the first malaria conference, Vivax Malaria Research: 2002 and Beyond, devoted entirely to Plasmodium vivax research.
openaire   +3 more sources

The paroxysm of Plasmodium vivax malaria

Trends in Parasitology, 2003
The paroxysms of Plasmodium vivax malaria are antiparasite responses that, although distressing to the human host, almost never impart serious acute pathology. Using plasma and blood cells from P. vivax patients, the cellular and noncellular mediators of these events have been studied ex vivo. The host response during a P.
Richard Carter, Kamini Mendis, S.K. Wijesekera, Nadira D. Karunaweera, Deepani Wanasekera   +4 more
openaire   +3 more sources

PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?

The Lancet, 1989
Two soldiers continued weekly prophylaxis with 300 mg chloroquine base on their return to Australia from Papua New Guinea but were not protected against Plasmodium vivax malaria. Both had symptoms and parasitaemia although plasma concentrations of chloroquine were considerably higher than those regarded as adequate for suppression of vivax malaria ...
D.C. Hutton, Karl H. Rieckmann, D.R. Davis   +2 more
openaire   +3 more sources

Primaquine Resistance in Plasmodium vivax

The American Journal of Tropical Medicine and Hygiene, 1996
Reports have appeared calling attention to what has been termed primaquine resistance in Plasmodium vivax in several geographic areas. The possibility exists that primaquine tolerant strains (often referred to as the tropical zone type from the South Pacific and Southeast Asian regions characterized by early and frequent relapses) may have become ...
Geoffrey M. Jeffery, William E. Collins
openaire   +3 more sources

Plasmodium vivax in Oceania

2016
Of the five species of malaria parasites infecting humans, Plasmodium vivax has the widest global distribution, with more than 80 million people infected each year (Price et al. Am J Trop Med Hyg 77:79–87, 2007) and 2.5 billion people at risk (Gething et al. PLoS Negl Trop Dis 6:e1814, 2012).
Moses Laman, Ivo Mueller, Lyndes Wini, Leanne J. Robinson   +3 more
openaire   +2 more sources